CD4+ NKG2D+ T cells induce NKG2D down-regulation in natural killer cells in CD86-RAE-1ε transgenic mice

Immunology

Volumn 141, Issue 3, 2014, Pages 401-415

  Lin, Zhijie ^a   Wang, Changrong ^a   Xia, Haizui ^a   Liu, Weiguang ^a   Xiao, Weiming ^a   Qian, Li ^a   Jia, Xiaoqin ^a   Ding, Yanbing ^a   Ji, Mingchun ^a   Gong, Weijuan ^a  

^a YANGZHOU UNIVERSITY   (China)

Author keywords

Natural killer; NKG2D; Regulation; Retinoic acid early transcript 1; Transgenic mouse

Indexed keywords

CD3 ANTIGEN; CD86 ANTIGEN; GAMMA INTERFERON; NATURAL KILLER CELL RECEPTOR NKG2A; NATURAL KILLER CELL RECEPTOR NKG2D; RETINOIC ACID EARLY TRANSCRIPT 1 EPSILON; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

ADAPTIVE IMMUNITY; ADOPTIVE TRANSFER; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN PRESENTING CELL; ARTICLE; BODY WEIGHT; BONE MARROW CELL; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; CYTOTOXICITY; CYTOTOXICITY ASSAY; DENDRITIC CELL; DEXTRAN SODIUM SULFATE-INDUCED COLITIS; DOWN REGULATION; ENZYME LINKED IMMUNOSORBENT ASSAY; EPITHELIUM CELL; EX VIVO STUDY; FLOW CYTOMETRY; IMMUNOFLUORESCENCE; IN VIVO STUDY; MICROENVIRONMENT; MOUSE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SPLEEN CELL; T LYMPHOCYTE; T LYMPHOCYTE SUBPOPULATION; WESTERN BLOTTING; WILD TYPE;

NATURAL KILLER; NKG2D; REGULATION; RETINOIC ACID EARLY TRANSCRIPT-1; TRANSGENIC MOUSE;

ANIMALS; ANTIGENS, CD86; CD4-POSITIVE T-LYMPHOCYTES; CELLS, CULTURED; COLITIS; DENDRITIC CELLS; DEXTRAN SULFATE; DISEASE MODELS, ANIMAL; DOWN-REGULATION; KILLER CELLS, NATURAL; LIGANDS; MELANOMA, EXPERIMENTAL; MEMBRANE PROTEINS; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; NK CELL LECTIN-LIKE RECEPTOR SUBFAMILY K; POLY I-C; PROMOTER REGIONS, GENETIC; T-LYMPHOCYTES, REGULATORY; TIME FACTORS; TRANSFORMING GROWTH FACTOR BETA;

EID: 84893606576     PISSN: 00192805     EISSN: 13652567     Source Type: Journal    
DOI: 10.1111/imm.12203     Document Type: Article

References (47)

1. Jacobs B, Ullrich E. The interaction of NK cells and dendritic cells in the tumor environment: how to enforce NK cell and DC action under immunosuppressive conditions? Curr Med Chem 2012; 19:1771-9.
2. Marcenaro E, Carlomagno S, Pesce S, Moretta A, Sivori S. NK/DC crosstalk in anti-viral response. Adv Exp Med Biol 2012; 946:295-308.
3. Morandi B, Costa R, Falco M et al. Distinctive lack of CD48 expression in subsets of human dendritic cells tunes NK cell activation. J Immunol 2005; 175:3690-7.
4. Srivastava RM, Varalakshmi C, Khar A. The ischemia-responsive protein 94 (Irp94) activates dendritic cells through NK cell receptor protein-2/NK group 2 member D (NKR-P2/NKG2D) leading to their maturation. J Immunol 2008; 180:1117-30.
5. Newman KC, Riley EM. Whatever turns you on: accessory-cell-dependent activation of NK cells by pathogens. Nat Rev Immunol 2007; 7:279-91.
6. Lucas M, Schachterle W, Oberle K, Aichele P, Diefenbach A. Dendritic cells prime natural killer cells by trans-presenting interleukin 15. Immunity 2007; 26:503-17.
7. Vitale M, Della-Chiesa M, Carlomagno S, Pende D, Aricò M, Moretta L, Moretta A. NK-dependent DC maturation is mediated by TNF-α and IFN-γ released upon engagement of the NKp30 triggering receptor. Blood 2005; 106:566-71.
8. Castriconi R, Cantoni C, Della-Chiesa M et al. Transforming growth factor β1 inhibits expression of NKp30 and NKG2D receptors: consequences for the NK-mediated killing of dendritic cells. Proc Natl Acad Sci USA 2003; 100:4120-5.
9. Hayakawa Y. Targeting NKG2D in tumor surveillance. Expert Opin Ther Targets 2012; 16:587-99.
10. Champsaur M, Lanier LL. Effect of NKG2D ligand expression on host immune responses. Immunol Rev 2010; 235:267-85.
11. Bauer S, Groh V, Wu J, Steinle A, Phillips JH, Lanier LL, Spies T. Activation of NK cells and T cells by NKG2D, a receptor for stress inducible MICA. Science 1999; 285:727-9.
12. Cerwenka A, Baron JL, Lanier LL. Ectopic expression of retinoic acid early inducible-1 gene (RAE-1) permits natural killer cell-mediated rejection of a MHC class I-bearing tumor in vivo. Proc Natl Acad Sci USA 2001; 98:11521-6.
13. Takada A, Yoshida S, Kajikawa M et al. Two novel NKG2D ligands of the mouse H60 family with differential expression patterns and binding affinities to NKG2D. J Immunol 2008; 180:1678-85.
14. Krmpotic A, Hasan M, Loewendorf A et al. NK cell activation through the NKG2D ligand MULT-1 is selectively prevented by the glycoprotein encoded by mouse cytomegalovirus gene m145. J Exp Med 2005; 201:211-20.
15. + T cells by NKG2D via engagement by MIC induced on virus-infected cells. Nat Immunol 2001; 2:255-60.
16. Spies T. Induction of T cell alertness by bacterial colonization of intestinal epithelium. Proc Natl Acad Sci USA 2002; 99:2584-6.
17. Jinushi M, Takehara T, Tatsumi T et al. Autocrine/paracrine IL-15 that is required for type I IFN-mediated dendritic cell expression of MHC class I-related chain A and B is impaired in hepatitis C virus infection. J Immunol 2003; 171:5423-9.
18. Wiemann K, Mittrücker HW, Feger U, Welte SA, Yokoyama WM, Spies T, Rammensee HG, Steinle A. Systemic NKG2D down-regulation impairs NK and CD8 T cell responses in vivo. J Immunol 2005; 175:720-9.
19. Oppenheim DE, Roberts SJ, Clarke SL, Filler R, Lewis JM, Tigelaar RE, Girardi M, Hayday AC. Sustained localized expression of ligand for the activating NKG2D receptor impairs natural cytotoxicity in vivo and reduces tumor immunosurveillance. Nat Immunol 2005; 6:928-37.
20. Kaiser BK, Yim D, Chow IT et al. Disulphide-isomerase-enabled shedding of tumour-associated NKG2D ligands. Nature 2007; 447:482-6.
21. Groh V, Wu J, Yee C, Spies T. Tumour-derived soluble MIC ligands impair expression of NKG2D and T-cell activation. Nature 2002; 419:734-8.
22. Coudert JD, Scarpellino L, Gros F, Vivier E, Held W. Sustained NKG2D engagement induces cross-tolerance of multiple distinct NK cell activation pathways. Blood 2008; 111:3571-8.
23. Qian L, Ji MC, Pan XY, Gong WJ, Tian F, Duan QF. Construction of a plasmid for co-expression of mouse membrane-bound form of IL-15 and RAE-1ε and its biological activity. Plasmid 2011; 65:239-45.
24. Wirtz S, Neufert C, Weigmann B, Neurath MF. Chemical induced mouse models of intestinal inflammation. Nat Protoc 2007; 2:541-6.
25. Cerwenka A, Bakker AB, McClanahan T, Wagner J, Wu J, Phillips JH, Lanier LL. Retinoic acid early inducible genes define a ligand family for the activating NKG2D receptor in mice. Immunity 2000; 12:721-7.
26. Jinushi M, Vanneman M, Munshi NC et al. MHC class I chain-related protein A antibodies and shedding are associated with the progression of multiple myeloma. Proc Natl Acad Sci USA 2008; 105:1285-90.
27. + T cells are immunosuppressive and inversely correlated with disease activity in juvenile-onset lupus. J Exp Med 2009; 206:793-805.
28. Groh V, Smythe K, Dai Z, Spies T. Fas-ligand-mediated paracrine T cell regulation by the receptor NKG2D in tumor immunity. Nat Immunol 2006; 7:755-62.
29. Park YP, Choi SC, Kiesler P, Gil-Krzewska A, Borrego F, Weck J, Krzewski K, Coligan JE. Complex regulation of human NKG2D-DAP10 cell surface expression: opposing roles of the γc cytokines and TGF-β1. Blood 2011; 118:3019-27.
30. Markiewicz MA, Wise EL, Buchwald ZS, Pinto AK, Zafirova B, Polic B, Shaw AS. RAE1ε ligand expressed on pancreatic islets recruits NKG2D receptor-expressing cytotoxic T cells independent of T cell receptor recognition. Immunity 2012; 36:132-41.
31. Coudert JD, Zimmer J, Tomasello E, Cebecauer M, Colonna M, Vivier E, Held W. Altered NKG2D function in NK cells induced by chronic exposure to NKG2D ligand-expressing tumor cells. Blood 2005; 106:1711-7.
32. Dasgupta S, Bhattacharya-Chatterjee M, O'Malley BW Jr, Chatterjee SK. Inhibition of NK cell activity through TGF-β1 by down-regulation of NKG2D in a murine model of head and neck cancer. J Immunol 2005; 175:5541-50.
33. Ogasawara K, Hamerman JA, Hsin H et al. Impairment of NK cell function by NKG2D modulation in NOD mice. Immunity 2003; 18:41-51.
34. Champsaur M, Beilke JN, Ogasawara K, Koszinowski UH, Jonjic S, Lanier LL. Intact NKG2D-independent function of NK cells chronically stimulated with the NKG2D ligand Rae-1. J Immunol 2010; 185:157-65.
35. Sun C, Fu B, Gao Y, Liao X, Sun R, Tian Z, Wei H. TGF-β1 down-regulation of NKG2D/DAP10 and 2B4/SAP expression on human NK cells contributes to HBV persistence. PLoS Pathog 2012; 8:e1002594.
36. Diefenbach A, Tomasello E, Lucas M, Jamieson AM, Hsia JK, Vivier E, Raulet DH. Selective associations with signaling proteins determine stimulatory versus costimulatory activity of NKG2D. Nat Immunol 2002; 3:1142-9.
37. -/- mice. J Immunol 2013; 190:3639-47.
38. Groh V, Bruhl A, El-Gabalawy H, Nelson JL, Spies T. Stimulation of T cell autoreactivity by anomalous expression of NKG2D and its MIC ligands in rheumatoid arthritis. Proc Natl Acad Sci USA 2003; 100:9452-7.
39. + T cells specific for human cytomegalovirus. Eur J Immunol 2006; 36:3198-206.
40. + T cells of patients with Crohn's disease. Gastroenterology 2011; 141:217-26.
41. + T cells in Crohn's disease mediate inflammatory and cytotoxic responses through MICA interactions. Gastroenterology 2007; 132:2346-58.
42. Kjellev S, Haase C, Lundsgaard D, Urso B, Tornehave D, Markholst H. Inhibition of NKG2D receptor function by antibody therapy attenuates transfer-induced colitis in SCID mice. Eur J Immunol 2007; 37:1397-406.
43. Goodman WA, Cooper KD, McCormick TS. Regulation generation: the suppressive functions of human regulatory T cells. Crit Rev Immunol 2012; 32:65-79.
44. Lee HM, Bautista JL, Hsieh CS. Thymic and peripheral differentiation of regulatory T cells. Adv Immunol 2011; 112:25-71.
45. Strid J, Roberts SJ, Filler RB et al. Acute upregulation of an NKG2D ligand promotes rapid reorganization of a local immune compartment with pleiotropic effects on carcinogenesis. Nat Immunol 2008; 9:146-54.
46. Strid J, Sobolev O, Zafirova B, Polic B, Hayday A. The intraepithelial T cell response to NKG2D-ligands links lymphoid stress surveillance to atopy. Science 2011; 334:1293-7.
47. Park EJ, Takahashi I, Ikeda J et al. Clonal expansion of double-positive intraepithelial lymphocytes by MHC class I-related chain A expressed in mouse small intestinal epithelium. J Immunol 2003; 171:4131-9.